atlasStrong
2026-02-25 · earnings-review · Q2 FY26 delivered another step-up in both revenue and profitability — $268M · Conviction 4/5
Open analysis → · PDF unavailable
Preview
# CRDO — Q2 FY26 Earnings Review (Atlas)
> Date: 2026-02-23
> Quarter: Q2 FY26 (October 2025) | Full results: Dec 1, 2025
> Q3 FY26 Preliminary: $404-408M pre-announced Feb 9, 2026 (full results March 2, 2026)
> Market cap: ~$23.3B | EV/TTM Rev: ~28x | Revenue growth: +272% YoY
---
## Verdict
Q2 FY26 delivered another step-up in both revenue and profitability — $268M (+272% YoY), record non-GAAP operating margin of 46.3%, and a 5th consecutive guidance beat. The more important signal is the Q3 FY26 pre-announcement: $404-408M vs $335-345M guided — a $63-68M beat that represents QoQ re-acceleration from +20% to +51%. FY26 is now tracking >$1.3B vs an original $800M guide. Five pillars, four hyperscalers at 10%+, zero debt, $813M cash. The only open question is whether Q3 margins held at ~67% gross or compressed as guided (63.8-65.8% GAAP). Answer comes March 2. Conviction 4/5.
---
## Qualification Gate
| Criterion | Threshold | Actual | Pass/Fail |
|-----------|-----------|--------|-----------|
| Revenue YoY growth | >30% (>40% preferred) | +272% | **PASS** |
| Gross margin | >60% (>70% preferred) | 67.5% GAAP | **PASS** |
| Revenue per quarter | >$50M | $268M | **PASS** |
| Data availability | 4+ quarters | 12 quarters | **PASS** |
| Share dilution | <10% annual | +13.6% Q1FY24→Q2FY26 over 9Q (~7% annualized) | **PASS** (marginal — watch) |
| GAAP profitability trajectory | Improving or positive | GAAP op margin: 29.4%; GAAP profitable since Q3 FY25 | **PASS** |
---
## Six-Factor Score
| Factor | Rating | Detail |
|--------|--------|--------|
| Growth | Strong | +272% YoY; Q3 prelim +201% on a much larger base; QoQ re-accelerated to +51% |
| Trajectory | Flat/Complex | YoY decelerating by arithmetic (272% → 201%) but QoQ re-accelerated sharply (20% → 51%); FY26 guide raised 60%+ from initial |
| Margins | High/Expanding | GAAP GM 67.5% (+4.3pp YoY); NG op margin 46.3% (+34.8pp YoY); both all-time highs |
| Dominance | Dominant | 73-88% AEC market share; de
*…truncated*
Preview
# CRDO — Customer Revenue Reconstruction
**Date:** 2026-03-03 | **Analyst:** wsm007 | **Type:** Supplementary Analysis
---
## Customer Identity Map
| Customer | Evidence | Confidence |
|---|---|---|
| **Amazon (AWS)** | Named in SEC warrant filing ($201M cumulative threshold), CFO named on Q3 FY25 call, AWS CEO LinkedIn purple cable photo | **Confirmed** |
| **Microsoft** | Barclays analyst named (CEO unchallenged), HiWire SWITCH press release quotes MSFT exec, Needham analyst confirmed, SemiAnalysis 2023 report | **Confirmed** |
| **xAI** | CEO named at Barclays conference (Sept 2025), Colossus 2 purple cable photos from Musk, Needham analyst confirmed | **Confirmed** |
| **Meta** | CEO confirmed at Goldman conference ("purple cables... all NVIDIA gear"), OCP Summit rack display | **Confirmed** |
| **Oracle** | CEO named at Barclays (ZF Optics customer, links too long for AEC), co-chair OCP Optics Reliability Workstream | **Confirmed (ZF Optics, not AEC)** |
| **Google** | No direct evidence found | **Speculative** (likely 5th hyperscaler) |
**Key sources:**
- SEC: Amazon warrant in 10-K (crdo-20250503)
- Transcripts: Q3 FY25 (CFO named Amazon), Q2 FY26 (CFO: "#2 at 24% = first hyperscaler to ramp")
- Conferences: Barclays Sept 2025 (Microsoft named by analyst, xAI named by CEO), Goldman Sept 2025 (Meta confirmed)
- Analysts: Needham (Quinn Bolton) confirmed Amazon, Microsoft, xAI
- Media: CNBC "500 purple cables" (Oct 2025), Benzinga analyst roundup (Mar 2025)
---
## Cross-Quarter Linkages (from Q3 FY26 transcript)
- Q3 Top 1 (39%) = "same customer as Q1's largest" + "quite a large increase Q2→Q3" → **xAI**
- Q3 Top 2 (32%) = "was largest customer in Q2" → **Amazon**
- Q3 Top 3 (17%) = "first hyperscaler to ramp" → **Microsoft**
- Q2 Top 2 (24%) = "first hyperscaler to ramp" (from Q2 transcript) → **Microsoft**
---
## Per-Customer Revenue Reconstruction ($M)
### Revenue by Customer
| Customer | Q3 FY25 (Jan-25) | Q4 FY25 (Apr-25) | Q1 FY26 (Jul-25) | Q2
*…truncated*
philAvoid
2026-03-15 · earnings-review · The March 2 results have converted my prior "hold, await clarity" into a more emphatic position
Open analysis → · PDF unavailable
Preview
---
ticker: CRDO
task: earnings-review
period: Q3_FY26 (Full Results)
date: 2026-03-02
analyst: Phil Fisher
prior: CRDO_earnings-review_Q3_FY26.md (preliminary, 2026-02-22)
---
# Credo Technology (CRDO) — Q3 FY26 Full Earnings Review
**Philip A. Fisher | March 2, 2026**
---
## Preface
Three weeks ago, I wrote my preliminary assessment of Credo's Q3 FY26 based on the revenue pre-announcement alone. I stated plainly that the one unresolved question — the 22-point gap between GAAP and non-GAAP gross margins — must await today's full results. Today is March 2, and the results are in. I can now speak with the confidence that complete data affords.
The answer is unambiguous. The concern I flagged was not merely resolved — it was demolished.
---
## The Margin Question Answered
This was the central tension from my February analysis. Management had guided Q3 non-GAAP gross margin at 64–66%, a meaningful step-down from Q2's 67.7%. I noted a separate and more troubling figure — a ~45% non-GAAP gross margin reference for full-year FY26 that created a 22-point gap versus GAAP. I flagged this as the one dimension I could not score until today.
The Q3 actual results:
| Metric | Q2 FY26 | Q3 FY26 Guide | Q3 FY26 Actual |
|--------|---------|---------------|----------------|
| GAAP Gross Margin | 67.5% | 63.8–65.8% | **68.5%** |
| Non-GAAP Gross Margin | 67.7% | 64.0–66.0% | **68.6%** |
Management guided gross margins down by 200–380 basis points. Instead, margins expanded by 100 basis points — to 68.5% GAAP and 68.6% non-GAAP. This is the second consecutive quarter in which Credo guided margins conservatively and then exceeded the high end.
The ~45% figure I questioned was, as other analysts in this corpus suspected, almost certainly a mislabeled reference to non-GAAP operating margin or net margin targets, not gross margin. With Q3 non-GAAP operating margin at 49.6% and non-GAAP net margin at 51.3%, even those metrics have now substantially exceeded the ~45% figure. Th
*…truncated*
Preview
---
# CRDO — Q3 FY26 Earnings Review (Preliminary)
**Date:** 2026-02-22 | **GauchoRico** | *First look — no prior GR corpus on CRDO*
---
## Headline
Holy smokes!! Credo Technology just delivered the largest beat in its public company history — $406M preliminary vs. a $340M guide midpoint, a 19% upside that adds ~$63-68M in a single quarter. FY26 implied revenue crossed $1.3B and the company raised full-year guidance to >200% growth. This is not a normal quarter for a semiconductor business.
That said, this is a preliminary release. The full earnings call is March 2, 2026. There is one open question so alarming that it could change the thesis: a non-GAAP gross margin guide of ~45% against a GAAP GM of 67.5%. Until that contradiction is resolved, I am treating this as a conditional buy.
---
## Atlas Baseline Read
Atlas scored CRDO at conviction 4/5 with a six-factor rating that I largely agree with. Atlas correctly identified the GM discrepancy as "the critical question for March 2." It weighted the 5-consecutive-beat pattern over the literal Q4 sequential guide (mid-single digits), which I think is right — management has been systematically under-promising by 15-20%+ for five straight quarters. The bear case Atlas flagged — customer concentration and AI capex cycle dependency — are real, but concentration is improving (2 → 4 customers >10%). I agree with the 4/5 conviction. My own read adds more weight to the gross margin question and the LEAPS opportunity if the March 2 call clears it up.
---
## 12-Quarter Revenue Table
| | Q4_FY23 | Q1_FY24 | Q2_FY24 | Q3_FY24 | Q4_FY24 | Q1_FY25 |
| | Apr-23 | Jul-23 | Oct-23 | Jan-24 | Apr-24 | Jul-24 |
|---|---|---|---|---|---|---|
| Revenue ($m) | 32.1 | 35.1 | 44.0 | 46.6* | 60.8* | 59.7 |
| QoQ % | -40.9% | +9.4% | +25.4% | +5.7% | +30.5% | -1.8% |
| YoY % | -14.4% | -24.5% | -14.4% | — | +30.5% | +70.1% |
| GAAP GM % | — | — | — | — | — | — |
| GAAP Op Margin % | — | — | — | — | — | — |
| | Q2_FY25 | Q3_FY25 | Q4_
*…truncated*
Preview
# CRDO — Earnings Review: Q3 FY26 (Full Results)
**Date:** 2026-03-03 | **Analyst:** Bear (PaulWBryant) | **Quarter:** Q3 FY26 (Jan 2026)
**Position:** None (evaluating)
---
## Prior Beliefs / Updated Beliefs
I wrote five open questions on February 22nd when the prelim dropped. Let me be honest about how each resolved.
**Prior Belief #1: Q3 GAAP gross margin — did 67.5% hold at $406M revenue?**
→ Updated: 68.5% GAAP. Not only held — expanded. Beat the high end of guidance by 270bps. I could not have been more wrong to worry about this. Fleming guided 63.8-65.8% and delivered 68.5%. Third consecutive quarter of systematic margin guidance undershoot. The "45% non-GAAP" confusion from the prelim was indeed a misattribution to operating margin. Resolved cleanly.
**Prior Belief #2: Clarify 45% non-GAAP guidance — operating margin, not gross margin?**
→ Updated: Confirmed. Non-GAAP operating margin: 49.6%. Non-GAAP gross margin: 68.6%. GAAP/NG spread on GM is 10bps — trivially small. The large spread is at the operating line (36.8% GAAP vs 49.6% NG), driven by $52.2M SBC (12.8% of revenue, down from 16.9% Q2). No mystery.
**Prior Belief #3: Formal Q4 guidance vs "mid-single-digit sequential" language**
→ Updated: $425-435M. Midpoint $430M = +6.1% QoQ. GM guided 64-66%. Based on the three-quarter pattern (250-270bps beats on GM), I'd expect actual Q4 revenue of $460-490M and GM of 67%+. But that's speculation, not conviction.
**Prior Belief #4: Did 5th hyperscaler cross 10%?**
→ Updated: No. 10%+ customers dropped from 4 to 3. Fourth hyperscaler's results were "in line with expectations from 90 days ago" but the largest customer's upside changed the denominator. Top-3 combined: 88% (up from 82% Q2). This gives me pause.
**Prior Belief #5: Cash buildup explanation**
→ Updated: ATM equity program. Cash: $813.6M → $1,301.5M (+$487.9M). FCF was $139.7M, leaving ~$348M from ATM. Raising equity while stock is strong, building a fortress. $1.3B cash, zero debt. Sensible c
*…truncated*
saul—
2026-02-25 · earnings-review · CRDO just delivered the biggest beat in its history — $406 million versus guidance of $335–345 million
Open analysis → · PDF unavailable
Preview
# CRDO — Earnings Review, Q3 FY26
**Date:** 2026-02-22 | **Analyst:** Saul Rosenthal
**Quarter:** Q3 FY26 (ended January 31, 2026) — PRELIMINARY RESULTS
**Official results + transcript:** March 2, 2026
---
## Verdict
CRDO just delivered the biggest beat in its history — $406 million versus guidance of $335–345 million. That is a $63–68 million upside, roughly 19% above the midpoint. And the company raised its full-year FY26 growth outlook from 170% to more than 200%.
You know what that means? It means demand picked up SHARPLY late in the quarter. And management said exactly that. This is the opposite of deceleration. This is re-acceleration.
**Thesis: Strengthening. I am not adding pre-March 2 — but if the margins hold up on the official results, I would be a buyer.**
---
## Revenue Trajectory — The Only Thing That Matters First
| | Q3_FY25 | Q4_FY25 | Q1_FY26 | Q2_FY26 | Q3_FY26* |
| | Jan-25 | Apr-25 | Jul-25 | Oct-25 | Jan-26 |
|---|---|---|---|---|---|
| Revenue ($m) | 135.0 | 170.0 | 223.1 | 268.0 | 406.0 |
| YoY % | +154% | +180% | +274% | +272% | +201% |
| QoQ % | +36% | +26% | +31% | +20% | +51% |
*Preliminary, unaudited. Official results March 2.
Look at that QoQ column. After decelerating from +36% to +26% to +31% to +20%, we get FIFTY-ONE PERCENT sequential growth. That is such a preposterous result! The revenue went from $268 million to $406 million in a single quarter. That's $138 million of new revenue added in 90 days.
Yes, YoY decelerated from 272% to 201%. But that is a math problem — we are lapping the massive ramp that started in Q3 FY25. The QoQ re-acceleration tells the real story. Demand is not slowing. Demand is accelerating.
---
## Multi-Quarter Financial Table (Latest Complete Data = Q2 FY26)
| | Q1_FY25 | Q2_FY25 | Q3_FY25 | Q4_FY25 | Q1_FY26 | Q2_FY26 |
| | Jul-24 | Oct-24 | Jan-25 | Apr-25 | Jul-25 | Oct-25 |
|---|---|---|---|---|---|---|
| Revenue ($m) | 59.7 | 72.0 | 135.0 | 170.0 | 223.1 | 268.0 |
| YoY % | +70% | +64% |
*…truncated*
Preview
# CRDO — Earnings Review: Q3 FY26 (Full Results)
**Date:** 2026-03-03 | **Analyst:** StockNovice (Joe) | **Quarter:** Q3 FY26 (Jan 2026)
---
## The Headline
Credo started March with what I consider an absolute monster of a quarter. And I don't throw that word around lightly.
$407M revenue. +201% YoY. +52% QoQ. Beat their own guide by $67M — that's not a rounding error, that's a whole extra quarter for the company they were two years ago. Fifth consecutive beat-and-raise. Every margin metric at record levels. FCF inflecting to $140M from $39M last quarter.
Here's the thing — I had four red flags pinned to my board going into this report. Every single one resolved in Credo's favor. That... doesn't happen very often.
---
## Pre-Earnings Homework: What I Was Watching
When the prelim dropped on February 9th, I flagged these open items:
**1. The gross margin mystery.** There was this weird 45% "gross margin" guidance floating around that didn't reconcile with the 67.5% GAAP GM they'd been printing. Was the company actually guiding for a 22-point margin collapse?
**Verdict:** Nope. It was a mislabeled operating margin figure, just like I suspected. Actual Q3 GAAP GM: 68.5%. Non-GAAP GM: 68.6%. Beat the guided range of 63.8-65.8% by 270 basis points on the high end. This wasn't close. The margin concern is dead.
**2. Customer concentration direction.** Top-3 customers at 82% in Q2, with the 4th hyperscaler just crossing 10%. Were they diversifying?
**Verdict:** Mixed. Top-1 dropped from 42% to 39% — that's the right direction. But Top-2 surged from 24% to 32%, and Top-3 held at 17%. Combined top-3: 88%. That's *worse* than Q2's 82%. The 4th hyperscaler actually fell back below 10%. I'll talk more about this below because it's the one wart on an otherwise flawless report.
**3. Q4 formal guidance.** Would they just say "mid-single-digit sequential" or give real numbers?
**Verdict:** Real numbers: $425-435M. GM 64-66%. Based on the beat pattern, I'd pencil in som
*…truncated*
Preview
# CRDO — Credo Technology | Q3 FY26 Earnings Review (Preliminary)
*muji (CMF_muji) | 2026-02-22 | HHHYPERGROWTH*
**Note: This is based on the Q3 FY26 PRELIMINARY release only. Full results + transcript: March 2, 2026 after market.**
long CRDO ~10%
---
## Links
- Q3 FY26 Preliminary Press Release: [Credo Technology IR](https://investors.credosemi.com)
- Full results + call: March 2, 2026, 2:00 PM PT
- Prior analysis: First muji writeup on CRDO
---
## The Headline Number
$404-408M (prelim) vs $335-345M guide.
Let me put that in context. Management guided $340M midpoint. They printed $406M midpoint. That's a **+$66M beat, ~19% above the top of the range**. On a run rate basis that's a company guide of ~$1.36B annualized that printed at ~$1.62B.
Revenue trajectory:
| | Q3_FY25 | Q4_FY25 | Q1_FY26 | Q2_FY26 | Q3_FY26 (prelim) |
| | Jan-25 | Apr-25 | Jul-25 | Oct-25 | Jan-26 |
|---|---|---|---|---|---|
| Revenue ($m) | 135 | 170 | 223 | 268 | 406 |
| YoY % | — | +180% | +274% | +272% | +201% ^^ |
| QoQ % | — | +26% | +31% | +20% | +51% !! |
| Beat vs guide | +$10M | +$15M | +$28M | +$28M | +$66M !!! |
| GM [GAAP] | 64.1% | 67.4% | 67.4% | 67.5% | TBD (Mar 2) |
| Op margin [GAAP] | (10.5%) | 36.8% | 27.2% | 29.4% | TBD (Mar 2) |
That beat streak: +10 → +15 → +28 → +28 → +66 !!!
Five consecutive quarters of sandbagging, each wider than the last. But +$66M is not sandbagging. That's a **fundamental revision to demand visibility**. Something changed materially in Q3.
FY26 guide raised to >200% YoY. That implies ~$1.3B+ for the year. With Q3 prelim at $406M and three quarters done at $135+$170+$223+$268 = $796M... wait, that's only the first three. Let me recalculate: Q1+Q2+Q3 = $223+$268+$406 = $897M. FY26 ends April 2026. So Q4 needs to bring it to whatever >200% implies off FY25 base.
FY25 revenue was approximately $223+$170 (Q4)+earlier quarters. From the data: FY25 TTM was roughly $435-440M. >200% of that = >$1.31B. With $897M in first three quarters, Q4 need
*…truncated*
Preview
# CRDO — Q3 FY26 Earnings Review (Bert Hochfeld)
> Date: 2026-04-28
> Quarter: Q3 FY26 (ended Jan 31, 2026; reported March 2, 2026)
> Stock: $94.21 (last close used in 3/31 analysis) | Market cap: $17.6B | EV: ~$16.3B
> FY ends: April
## Summary
I initiated coverage of Credo on March 31 with a Buy at 3-4% target weight. Returning now to the Q3 FY26 print in proper earnings-review format, the conclusions only firm up. Revenue of $407M came in at +201.5% YoY and +51.9% sequentially, beating the guide midpoint by $67M, or 19.7% — the largest beat-and-raise in company history and the fifth consecutive quarter of widening beat magnitude. Non-GAAP gross margin of 68.6% was 260bp above the high end of guidance, non-GAAP operating margin of 49.6% set a record, and free cash flow of $139.7M (34.3% of revenue) marked the cash-flow inflection point I had been waiting for. The Rule of 40 score is 235. Q4 FY26 revenue is guided to $425-$435M with non-GAAP gross margin of 64.0-66.0% — a guidance pattern that, on my read of the prior five quarters, is deliberately undemanding. FY27 commentary points to "nearly $2B" of revenue, more than 50% YoY. None of this is reflected in a stock that remains 56% off its $213.80 peak. **Recommendation: Buy. 3-4% initial weight, add to 5-6% on Q4 margin confirmation.** Thesis status moves from Intact (New Coverage) to **Strengthening**.
## Headline KPIs (Q3 FY26)
- **Revenue:** $407.0M | YoY +201.5% | QoQ +51.9% | Beat guide by +$67M (+19.7%)
- **Non-GAAP GM:** 68.6% (guide: 64.0-66.0%) | GAAP GM: 68.5%
- **Non-GAAP Op Margin:** 49.6% (record, +327bp QoQ) | GAAP Op Margin: 36.8%
- **Non-GAAP Net Margin:** 51.3% | Non-GAAP EPS: $1.07 vs consensus $0.94
- **OCF:** $166.2M | **FCF:** $139.7M (34.3% margin) | **Cash + ST inv:** $1,301.5M | **Debt:** $0
- **AEC ≈ 80% of revenue** | AEC product GM ≈ 72% | IC solutions GM ≈ 62%
- **Customers >10%:** 3 (39%, 32%, 17% — top-3 = 88%)
- **RPO:** $33.9M (Q2 disclosure; Q3 not separately quantified)
- **
*…truncated*
Rolling earnings (raw)
# CRDO Rolling Earnings Tracker
> Last Updated: 2026-02-11
> Fiscal Year End: April
## Quarterly Revenue Progression
| Quarter | Revenue | YoY | QoQ | GM% | Op Margin% | EPS |
|---------|---------|-----|-----|-----|------------|-----|
| Q3 FY25 (Jan '25) | $135m | +154% | +36% | 64.0% | 31.4% | $0.25 |
| Q4 FY25 (Apr '25) | $170m | +180% | +26% | 67.4% | 36.8% | $0.35 |
| Q1 FY26 (Jul '25) | $223m | +274% | +31% | 67.6% | 43.1% | $0.52 |
| Q2 FY26 (Oct '25) | $268m | +272% | +20% | 67.6% | ~44% | $0.67 |
| Q3 FY26 (Jan '26) | $407m | +201% | +52% | 68.6% | 49.6% | $1.07 |
**TTM Revenue:** ~$1.07B (through Q3 FY26)
**FY26 YTD (9 months):** $898.1m
## Q3 FY26 Full Results (March 2, 2026)
- **Revenue:** $407.0m vs $335-345m guide — **+$67m beat (+19.7%), largest in company history**
- **QoQ:** +51.9% sequential (vs +20.2% in Q2) — massive re-acceleration
- **YoY:** +201.5% growth
- **GAAP GM:** 68.5% (guided 63.8-65.8% — beat high end by 270bps)
- **Non-GAAP GM:** 68.6% (guided 64.0-66.0% — beat high end by 260bps)
- **GAAP Op Margin:** 36.8% (up from 29.4% Q2)
- **Non-GAAP Op Margin:** 49.6% (up from 46.3% Q2)
- **GAAP EPS:** $0.82 | **Non-GAAP EPS:** $1.07 (consensus was $0.94)
- **GAAP Net Income:** $157.1m | **Non-GAAP Net Income:** $208.8m
- **Cash + ST Investments:** $1,301.5m (up from $813.6m Q2)
- **SBC:** $52.2m (12.8% of revenue, down from 16.9% Q2)
- **R&D:** $78.5m (+35.6% QoQ)
- **CoMira Solutions acquisition completed** — link layer, ECC, security IP
- **Toucan PCIe Retimer achieved PCI-SIG compliance**
- **224G multiprotocol AI scale-up retimer announced** (UALink, ESUN, Ethernet)
- **Q4 FY26 guide:** $425-435m revenue; GAAP GM 63.9-65.9%; NG GM 64.0-66.0%
- **FY26 full year:** ~$1.33B (>200% YoY confirmed)
## Full Year Actuals & Guidance
| Fiscal Year | Revenue | YoY Growth | GM% | Net Margin% |
|-------------|---------|------------|-----|-------------|
| FY24 | $193m | +17% | ~57% | N/A |
| FY25 | $437m | +126% | 65.0% | ~30% |
| FY26 (Guide) | >$1.3B | >200% | 65-68% | ~40% |
## Beat/Miss History
| Quarter | Rev Guide | Rev Actual | Beat | EPS Guide | EPS Actual | Beat |
|---------|-----------|------------|------|-----------|------------|------|
| Q3 FY25 | $115-125m | $135m | +$10m | $0.18 | $0.25 | +$0.07 |
| Q4 FY25 | $145-155m | $170m | +$15m | ~$0.24 | $0.35 | +$0.11 |
| Q1 FY26 | $185-195m | $223m | +$28m | ~$0.40 | $0.52 | +$0.12 |
| Q2 FY26 | $230-240m | $268m | +$28m | $0.50 | $0.67 | +$0.17 |
| Q3 FY26 | $335-345m | $407.0m | +$67m | $0.94 | $1.07 | +$0.13 |
**Consecutive Beats:** 5 quarters (and counting)
**Average Revenue Beat:** ~$34m (~17% above midpoint)
## Customer Concentration Trend
| Quarter | 10%+ Customers | Largest | Second | Third | Fourth |
|---------|----------------|---------|--------|-------|--------|
| Q3 FY25 | 2 | ~60% | ~15% | <10% | - |
| Q4 FY25 | 3 | 61% | 12% | 11% | - |
| Q1 FY26 | 3 | 35% | 33% | 20% | <10% |
| Q2 FY26 | 4 | ~30% | ~25% | ~20% | ~12% |
**Trend:** Steady improvement in customer diversification
## Product Mix Evolution
| Quarter | AEC % | Optical % | Retimer % | IP Licensing |
|---------|-------|-----------|-----------|--------------|
| Q3 FY25 | ~75% | ~15% | ~5% | ~5% |
| Q4 FY25 | ~80% | ~12% | ~5% | <5% |
| Q1 FY26 | ~82% | ~12% | ~5% | <3% |
| Q2 FY26 | ~80% | ~14% | ~5% | <3% |
**Note:** IP Licensing now <5% of revenue and no longer separately reported
## Key Guidance Progression
| Date | FY26 Rev Guide | Commentary |
|------|----------------|------------|
| Jun 2025 (Q4 FY25) | >$800m | Initial FY26 guide |
| Sep 2025 (Q1 FY26) | ~$960m | Raised to ~120% YoY |
| Dec 2025 (Q2 FY26) | >$1.0B | Raised again with new pillars |
| Feb 2026 (Q3 prelim) | >$1.3B implied | >200% YoY; mid-single-digit seq Q4 |
## TAM Evolution
| Date | Total Market Estimate | Commentary |
|------|----------------------|------------|
| Pre-2025 | ~$3B | AEC + Optical DSP + Retimers |
| Dec 2025 | >$10B | Added Zero Flap Optics, ALCs, OmniConnect |
## Promise Tracker
### FY26 Commitments (Made in Q4 FY25 - Q2 FY26)
| Promise | Status | Notes |
|---------|--------|-------|
| FY26 Revenue >$800m | ON TRACK | Now guided >$1.3B (>200% YoY); Q3 prelim $404-408m |
| Four 10%+ hyperscalers | ACHIEVED (Q2 FY26) | Diversification improving |
| Optical revenue 2x FY25 | ON TRACK | Exceeding target |
| PCIe design wins CY2025 | ON TRACK | Production rev CY2026 |
| Net margin ~40% | ACHIEVED | Actually above 40% |
| New product announcements | ACHIEVED | Zero Flap, ALCs, OmniConnect |
### Longer-Term Commitments
| Promise | Timeline | Status |
|---------|----------|--------|
| 100G AEC dominance | End FY26 | PROGRESSING - accelerating faster than expected |
| 3nm Optical DSP production | H2 FY26 | ON TRACK |
| PCIe retimer production revenue | CY2026 | ON TRACK |
| Fifth hyperscaler to 10%+ | FY27 | POSSIBLE |
## Key Metrics to Watch
1. **Customer Concentration** - Tracking toward <30% for largest customer
2. **100G Transition Rate** - Accelerating faster than expected
3. **Optical Revenue Growth** - Targeting 2x+ for FY26
4. **Gross Margin** - Stabilizing at 67-68% range
5. **New Pillar Revenue** - Zero Flap/ALCs contribution starting H2 FY26
6. **Q3 Margins** - ANSWERED: 68.5% GAAP GM, 68.6% NG GM — expanded despite guided step-down
7. **Q4 Formal Guide** - $425-435m; GAAP GM guided 63.9-65.9% (expect beat based on pattern)
## Risk Factors
1. **Customer Concentration** - Four hyperscalers still dominate
2. **Wafer Supply** - Industry-wide tightness noted
3. **Competition** - Emerging AEC competitors
4. **Tariffs** - Fluid regime, can relocate manufacturing in months
5. **New Product Execution** - Three new pillars require execution
## Source Log
| Date | Source | Update |
|------|--------|--------|
| 2026-02-11 | Q3 FY26 prelim press release (Feb 9) | Added prelim section, updated beat history, FY26 guide progression, promise tracker |
| 2026-02-21 | Atlas earnings review | Full analysis with valuation context, scuttlebut